← SynDRA
TOLAMOLOL
SynDRA canonical compound SYN0001281 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | ADRB1 | ADRB2 | ADRB3 |
| Mechanism of action | adrenergic receptor antagonist |
All known targets
Mechanisms of action (all sources)
- adrenergic receptor antagonist
Cross-references
Synonyms
- Tolamololum
- F03W3WUW58
- DTXCID2026230
- UK-6558-01
- totamidol
- RefChem:933169
- 4-(2-(2-hydroxy-3-o-tolyloxypropylamino)ethoxy)benzamide
- NCGC00160559-01
- p-(2-((2-Hydroxy-3-(o-tolyloxy)propyl)amino)ethoxy)benzamide
- Tolamololum [INN-Latin]
- UNII-F03W3WUW58
- Tolamolol [USAN:INN:BAN]
- SKQDKFOTIPJUSV-UHFFFAOYSA-N
- EINECS 253-783-8
- UK-6558
- TOLAMOLOL [INN]
- Tolamolol (USAN/INN)
- TOLAMOLOL [USAN]
- TOLAMOLOL [WHO-DD]
- SCHEMBL611643
- orb1819140
- Tox21_111899
- AKOS024343888
- CAS-38103-61-6
- NS00030335
- D06176
- T68164
- SR-01000944903
- SR-01000944903-1
- BRD-A60498477-001-01-2
- トラモロール
- 妥拉洛尔
- تولامولول
- TOLAMOLOL HYDROCHLORIDE [WHO-DD]
- UNII-25619NA95Y
- CCRIS 1054
- (+/-)-TOLAMOLOL HYDROCHLORIDE
- tolamolol hydrochloride
Look up TOLAMOLOL in the interactive SynDRA portal →